Differential effects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects

Phillip Anson Low, T. L. Opfer-Gehrking

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Tricyclic antidepressants, especially amitriptyline (AMI), are widely used by patients who require tests of autonomic function. AMI effects autonomic function, but its quantitative and differential effects are not known. We prospectively evaluated the effect of AMI on sudomotor (M3 receptor), cardiovagal (M2) and adrenergic functions in 6 subjects, aged 20-40 years before, during, and 48 hours after AMI 75 mg/d. M3 receptor function was evaluated using QSART (quantitative sudomotor axon reflex test) recordings from four sites, M2 receptor function from cardiovagal studies [HR response to deep breathing (HR(DB)) and the Valsalva ratio (VR)], and adrenergic function from an analysis of beat-to-beat BP responses to tilt and the Valsalva maneuver. Plasma AMI was determined from blood samples obtained within 2 hours of autonomic testing. QSART volume was reduced by 47% by AMI (P = 0.01), and recovered to 81% of baseline following a 48-hour washout. HR(DB) was unaffected by AMI (P > 0.05). VR was increased by 10% (NS) with AMI and by 14% (P < 0.05) with washout. The percent change in hemodynamic parameters by AMI were: orthostatic reduction in SBP, 62% (NS); orthostatic HR increment, 66%, (P = 0.03); and phase II(e) SBP decrement, 665%, (P = 0.02). We conclude that AMI in the moderate doses used, resulted in greater inhibition of M3 than M2 receptors. The BP, HR, and beat-to-beat BP alterations likely reflect adrenergic inhibition resulting in a reduction in effective plasma volume. A washout of 48 hours is adequate for muscarinic but not adrenoceptors.

Original languageEnglish (US)
Pages (from-to)1340-1344
Number of pages5
JournalMuscle and Nerve
Volume15
Issue number12
DOIs
StatePublished - 1992

Fingerprint

Amitriptyline
Adrenergic Agents
Axons
Reflex
Respiration
Valsalva Maneuver
Plasma Volume
Tricyclic Antidepressive Agents
Adrenergic Receptors
Cholinergic Agents
Hemodynamics

Keywords

  • adrenergic
  • amitriptyline
  • blood pressure
  • sudomotor

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Differential effects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects. / Low, Phillip Anson; Opfer-Gehrking, T. L.

In: Muscle and Nerve, Vol. 15, No. 12, 1992, p. 1340-1344.

Research output: Contribution to journalArticle

@article{b3526463abc1446e9a3aaf1f3678149e,
title = "Differential effects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects",
abstract = "Tricyclic antidepressants, especially amitriptyline (AMI), are widely used by patients who require tests of autonomic function. AMI effects autonomic function, but its quantitative and differential effects are not known. We prospectively evaluated the effect of AMI on sudomotor (M3 receptor), cardiovagal (M2) and adrenergic functions in 6 subjects, aged 20-40 years before, during, and 48 hours after AMI 75 mg/d. M3 receptor function was evaluated using QSART (quantitative sudomotor axon reflex test) recordings from four sites, M2 receptor function from cardiovagal studies [HR response to deep breathing (HR(DB)) and the Valsalva ratio (VR)], and adrenergic function from an analysis of beat-to-beat BP responses to tilt and the Valsalva maneuver. Plasma AMI was determined from blood samples obtained within 2 hours of autonomic testing. QSART volume was reduced by 47{\%} by AMI (P = 0.01), and recovered to 81{\%} of baseline following a 48-hour washout. HR(DB) was unaffected by AMI (P > 0.05). VR was increased by 10{\%} (NS) with AMI and by 14{\%} (P < 0.05) with washout. The percent change in hemodynamic parameters by AMI were: orthostatic reduction in SBP, 62{\%} (NS); orthostatic HR increment, 66{\%}, (P = 0.03); and phase II(e) SBP decrement, 665{\%}, (P = 0.02). We conclude that AMI in the moderate doses used, resulted in greater inhibition of M3 than M2 receptors. The BP, HR, and beat-to-beat BP alterations likely reflect adrenergic inhibition resulting in a reduction in effective plasma volume. A washout of 48 hours is adequate for muscarinic but not adrenoceptors.",
keywords = "adrenergic, amitriptyline, blood pressure, sudomotor",
author = "Low, {Phillip Anson} and Opfer-Gehrking, {T. L.}",
year = "1992",
doi = "10.1002/mus.880151208",
language = "English (US)",
volume = "15",
pages = "1340--1344",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Differential effects of amitriptyline on sudomotor, cardiovagal, and adrenergic function in human subjects

AU - Low, Phillip Anson

AU - Opfer-Gehrking, T. L.

PY - 1992

Y1 - 1992

N2 - Tricyclic antidepressants, especially amitriptyline (AMI), are widely used by patients who require tests of autonomic function. AMI effects autonomic function, but its quantitative and differential effects are not known. We prospectively evaluated the effect of AMI on sudomotor (M3 receptor), cardiovagal (M2) and adrenergic functions in 6 subjects, aged 20-40 years before, during, and 48 hours after AMI 75 mg/d. M3 receptor function was evaluated using QSART (quantitative sudomotor axon reflex test) recordings from four sites, M2 receptor function from cardiovagal studies [HR response to deep breathing (HR(DB)) and the Valsalva ratio (VR)], and adrenergic function from an analysis of beat-to-beat BP responses to tilt and the Valsalva maneuver. Plasma AMI was determined from blood samples obtained within 2 hours of autonomic testing. QSART volume was reduced by 47% by AMI (P = 0.01), and recovered to 81% of baseline following a 48-hour washout. HR(DB) was unaffected by AMI (P > 0.05). VR was increased by 10% (NS) with AMI and by 14% (P < 0.05) with washout. The percent change in hemodynamic parameters by AMI were: orthostatic reduction in SBP, 62% (NS); orthostatic HR increment, 66%, (P = 0.03); and phase II(e) SBP decrement, 665%, (P = 0.02). We conclude that AMI in the moderate doses used, resulted in greater inhibition of M3 than M2 receptors. The BP, HR, and beat-to-beat BP alterations likely reflect adrenergic inhibition resulting in a reduction in effective plasma volume. A washout of 48 hours is adequate for muscarinic but not adrenoceptors.

AB - Tricyclic antidepressants, especially amitriptyline (AMI), are widely used by patients who require tests of autonomic function. AMI effects autonomic function, but its quantitative and differential effects are not known. We prospectively evaluated the effect of AMI on sudomotor (M3 receptor), cardiovagal (M2) and adrenergic functions in 6 subjects, aged 20-40 years before, during, and 48 hours after AMI 75 mg/d. M3 receptor function was evaluated using QSART (quantitative sudomotor axon reflex test) recordings from four sites, M2 receptor function from cardiovagal studies [HR response to deep breathing (HR(DB)) and the Valsalva ratio (VR)], and adrenergic function from an analysis of beat-to-beat BP responses to tilt and the Valsalva maneuver. Plasma AMI was determined from blood samples obtained within 2 hours of autonomic testing. QSART volume was reduced by 47% by AMI (P = 0.01), and recovered to 81% of baseline following a 48-hour washout. HR(DB) was unaffected by AMI (P > 0.05). VR was increased by 10% (NS) with AMI and by 14% (P < 0.05) with washout. The percent change in hemodynamic parameters by AMI were: orthostatic reduction in SBP, 62% (NS); orthostatic HR increment, 66%, (P = 0.03); and phase II(e) SBP decrement, 665%, (P = 0.02). We conclude that AMI in the moderate doses used, resulted in greater inhibition of M3 than M2 receptors. The BP, HR, and beat-to-beat BP alterations likely reflect adrenergic inhibition resulting in a reduction in effective plasma volume. A washout of 48 hours is adequate for muscarinic but not adrenoceptors.

KW - adrenergic

KW - amitriptyline

KW - blood pressure

KW - sudomotor

UR - http://www.scopus.com/inward/record.url?scp=0026457348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026457348&partnerID=8YFLogxK

U2 - 10.1002/mus.880151208

DO - 10.1002/mus.880151208

M3 - Article

C2 - 1470198

AN - SCOPUS:0026457348

VL - 15

SP - 1340

EP - 1344

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 12

ER -